|4May 4, 5:25 PM ET

Essetifin SPA 4

4 · FENNEC PHARMACEUTICALS INC. · Filed May 4, 2020

Insider Transaction Report

Form 4
Period: 2020-04-30
Transactions
  • Purchase

    Common Stock

    2020-04-30$6.25/sh+768,000$4,800,0003,993,694 total
Footnotes (2)
  • [F1]Such shares were purchased in connection with an underwritten public offering by the issuer, which closed on May 4, 2020.
  • [F2]Dispositive power over the shares of common stock owned by Essetifin S.p.A. is shared by Enrico Cavazza, Silvia Cavazza, Francesca Cavazza, Martina Cavazza Preta and Paolo Cavazza. Each of Enrico Cavazza, Silvia Cavazza, Francesca Cavazza, Martina Cavazza Preta and Paolo Cavazza disclaims beneficial ownership of all shares of common stock held by Essetifin S.p.A. except to the extent of any pecuniary interest therein.

Documents

2 files